TWI662959B - Pharmacy oral medication device - Google Patents
Pharmacy oral medication device Download PDFInfo
- Publication number
- TWI662959B TWI662959B TW103138906A TW103138906A TWI662959B TW I662959 B TWI662959 B TW I662959B TW 103138906 A TW103138906 A TW 103138906A TW 103138906 A TW103138906 A TW 103138906A TW I662959 B TWI662959 B TW I662959B
- Authority
- TW
- Taiwan
- Prior art keywords
- viscous medium
- end portion
- joint
- medicine
- discharge port
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2024—Separating means having peelable seals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2027—Separating means having frangible parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0046—Cups, bottles or bags
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Hematology (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
一種藥劑類口服服藥裝置。其能夠將藥劑和黏性介質分別收納,攜帶方便,服藥時,在包覆單個藥劑的基礎上,能夠將被包覆後的單個藥劑與黏性介質進一步融合為一體,形成藥劑包覆介質。藥劑類口服服藥裝置(100)具有排出口形成接合部(106)。排出口形成接合部(106)具有第1傾斜接合部(106a)和第2傾斜接合部(106b)。第1傾斜接合部(106a)和第2傾斜接合部(106b)彼此的傾斜角度不同。和第2傾斜接合部(106b)相比,第1傾斜接合部(106a)的傾斜角度更為緩和。另外,第1傾斜接合部(106a)相對於第2傾斜接合部(106b)更靠進開端部(104)一側。通過將傾斜角度各不相同的第1傾斜接合部(106a)、第2傾斜接合部(106b)相連,從排出口流出的一定量的黏性介質可以平穩地排出。 An oral medication device for medicaments. The medicine and the viscous medium can be stored separately and are convenient to carry. When taking the medicine, based on the coating of a single medicine, the coated single medicine and the viscous medium can be further integrated into one to form a medicine-coated medium. The medicinal oral administration device (100) includes a discharge port forming joint (106). The discharge port forming joint (106) includes a first inclined joint (106a) and a second inclined joint (106b). The inclination angles of the first inclined joint portion (106a) and the second inclined joint portion (106b) are different from each other. The inclination angle of the first inclined joint portion (106a) is more gentle than that of the second inclined joint portion (106b). In addition, the first inclined joint portion (106a) is closer to the open end portion (104) than the second inclined joint portion (106b). By connecting the first inclined joint portion (106a) and the second inclined joint portion (106b) having different inclination angles, a certain amount of viscous medium flowing from the discharge port can be smoothly discharged.
Description
本發明提供一種用於口服藥劑的藥劑類口服服藥裝置,特別是涉及一種能夠在形成單個包覆藥劑的基礎上,進一步使單個包覆藥劑融為一體,形成介質包覆藥劑的服藥裝置。 The invention provides a medicament-type oral medication device for oral medicaments, and in particular relates to a medicament medication device capable of further merging a single coated medicament into a single body to form a single coated medicament on the basis of forming a single coated medicament.
下面根據圖21對已有技術的黏性藥品調製裝置10進行說明。黏性藥品調製裝置10的容器11是由一對原材料為聚丙烯或聚乙烯等材料的薄片面對面相黏合而製成,薄片與薄片間的部分形成密閉的空間12。不過,容器11的結構並不受此限制,只要其內部形成密閉空間就可以。 Next, a conventional viscous drug preparation device 10 will be described with reference to FIG. 21. The container 11 of the viscous drug preparation device 10 is made of a pair of sheets whose raw materials are polypropylene or polyethylene and the like are adhered face to face, and a portion 12 between the sheets forms a closed space 12. However, the structure of the container 11 is not limited to this, as long as a closed space is formed in the container 11.
上述容器11的密閉空間由隔離部13分隔成液體隔離室12a和藥劑隔離室12b。但是當液體隔離室12a內部的壓強升高時,隔離部13也可以令液體隔離室12a和藥劑隔離室12b之間形成連通。 The sealed space of the container 11 is partitioned into a liquid isolation chamber 12 a and a drug isolation chamber 12 b by a partition 13. However, when the pressure inside the liquid isolation chamber 12a increases, the isolation portion 13 may also establish communication between the liquid isolation chamber 12a and the drug isolation chamber 12b.
上述液體隔離室12a內收容淨化水、茶或果汁飲料等液體5,藥劑隔離室12b內收容上述黏性藥品調 製劑1。 The liquid isolation chamber 12a contains liquid 5 such as purified water, tea, or fruit juice, and the drug isolation chamber 12b contains the viscous drug preparation. Formulation 1.
用手緊握黏性藥品調製裝置10的容器11,液體隔離室12a和藥劑隔離室12b將受到外力壓迫,其內部的壓強增高,容器11的隔離部13不再起分隔液體隔離室12a和藥劑隔離室12b的作用,液體隔離室12a和藥劑隔離室12b之間形成連通。這時,液體隔離室12a內的液體5將與藥劑隔離室12b內的黏性藥品調製劑1相互混合,黏性藥品調製劑1被調製成黏性狀態。(專利文獻1) Hold the container 11 of the viscous drug preparation device 10 by hand, the liquid isolation chamber 12a and the drug isolation chamber 12b will be oppressed by external forces, and the internal pressure will increase. The isolation portion 13 of the container 11 will no longer separate the liquid isolation chamber 12a from the drug The function of the chamber 12b is to establish communication between the liquid isolation chamber 12a and the drug isolation chamber 12b. At this time, the liquid 5 in the liquid isolation chamber 12a and the viscous drug preparation 1 in the drug isolation chamber 12b are mixed with each other, and the viscous drug preparation 1 is prepared in a viscous state. (Patent Document 1)
專利文獻1:特開2003-137817號公報 Patent Document 1: JP 2003-137817
上述黏性藥品調製裝置10具有如下改善點。當用力緊握容器11時,隔離部13被破壞,這時收容在液體隔離室12a內的液體5和收容在藥劑隔離室12b內的黏性藥品調製劑1相互混合。即隔離部13是以與手握緊時相當的力被緊貼固定在容器11內的。 The above-mentioned viscous drug preparation device 10 has the following improvement points. When the container 11 is firmly gripped, the isolation portion 13 is destroyed. At this time, the liquid 5 contained in the liquid isolation chamber 12a and the viscous drug preparation 1 contained in the drug isolation chamber 12b are mixed with each other. That is, the partition 13 is tightly fixed in the container 11 with a force equivalent to that when the hand is gripped.
在將藥劑與果膠等黏性介質一同服下以輔助服藥時,即使藥劑和黏性介質被相鄰地配置在容器中,由於上述隔離部13的存在,要想混合該藥劑和黏性介質也需要付出較大的力量握緊容器。而且,對黏性介質施加握力時,還可能發生黏性介質大量飛散的不良情況。 When the medicine is taken together with a viscous medium such as pectin to assist in taking the medicine, even if the medicine and the viscous medium are arranged adjacent to each other in the container, it is necessary to mix the medicine and the viscous medium due to the existence of the isolation portion 13 It also takes a lot of effort to hold the container tightly. In addition, when a grip force is applied to a viscous medium, a problem that a large amount of the viscous medium is scattered may occur.
因此,本發明旨在提供一種以分離態收納藥劑和黏性介質,攜帶方便,服藥時,能夠在形成單個包覆藥劑的基礎上,將這些單個包覆藥劑進一步融為一體而形成介質包覆藥劑的藥劑類口服服藥裝置。 Therefore, the present invention aims to provide a medicament and a viscous medium in a separated state, which is convenient to carry. When taking the medicine, the single medicament can be further integrated into a single medium to form a medium coating. Oral medication device for medicaments.
本發明提供的藥劑類口服服藥裝置使用一定形狀的平面形材料成型,具有帶開口的開端部和閉合態的閉端部,在與上述開端部相對的位置上還有其他構造,且形狀為筒狀。該服藥裝置內收容有能夠包覆藥劑以及含有規定營養元素的營養形藥劑的黏性介質,該黏性介質可將上述被包覆藥劑進一步融為一體而形成介質包覆藥劑。將用於製作上述筒狀結構的平面形材料的第1側部和第2側部連接,接合相對位置上的成形材料形成中間接合部。上述中間接合部、上述側部以及上述閉端部圍成的空間用作封入上述黏性介質的黏性介質封入部。以上述第1側部和第2側部之間的某個特定位置為端點連接第1側部,並沿著從上述開端部向閉端部下降的方向連接相對位置上的上述成形材形成排出口形成接合部,上述端點的位置比上述中間接合部更靠近上述開端部。 The pharmaceutical oral administration device provided by the present invention is formed by using a flat material of a certain shape, and has an open end portion with an opening and a closed end portion in a closed state. There are other structures at positions opposite to the open end portions, and the shape is a tube. shape. The medicinal device contains a viscous medium capable of coating the medicinal agent and the nutrient-shaped medicinal agent containing a predetermined nutrient element, and the viscous medium can further fuse the coated agents into a medium to form a medium-coated medicinal agent. The first side portion and the second side portion of the planar material used to make the above-mentioned tubular structure are connected, and the forming materials at the opposite positions are joined to form an intermediate joint portion. A space surrounded by the intermediate joint portion, the side portion, and the closed end portion is used as a viscous medium sealing portion that seals the viscous medium. The first side portion is connected to the first side portion at a specific position between the first side portion and the second side portion, and the forming material at a relative position is formed in a direction of descending from the open end portion to the closed end portion. The discharge port forms a joint portion, and the end point is located closer to the open end portion than the intermediate joint portion.
黏性介質沿排出口形成接合部移動,可以被適度地截流,被截流後的黏性介質從第2側部與上述端點之間的排出口排出,這樣更易於使藥劑和黏性介質均勻地混合,形成介質包覆藥劑。 The viscous medium moves along the joint formed by the discharge port and can be moderately intercepted. The intercepted viscous medium is discharged from the discharge port between the second side portion and the above-mentioned endpoint, which makes it easier to make the medicine and the viscous medium uniform. Mixed together to form a medium-coated medicament.
在本發明提供的藥劑類口服服藥裝置中,上述第2側部上具有從上述開端部向上述閉端部呈上升狀的傾斜側部,該傾斜側部的位置與上述排出口形成接合部相對應。 In the medicinal oral administration device provided by the present invention, the second side portion has an inclined side portion that rises from the open end portion to the closed end portion, and the position of the inclined side portion forms a joint with the discharge port correspond.
這樣,黏性介質流過排出口形成接合部的同時沿傾斜側部流動,更有利於適度的截流。 In this way, the viscous medium flows along the inclined side while flowing through the discharge port to form the joint, which is more conducive to moderate interception.
在本發明提供的藥劑類口服服藥裝置中,排出口形成接合部沒有一定的傾斜角度,這是一個特徵。 In the medicinal oral medication device provided by the present invention, it is a feature that the discharge port forms a joint portion without a certain inclination angle.
這有助於黏性介質被適度截流。 This helps the viscous medium to be moderately blocked.
在本發明提供的藥劑類口服服藥裝置中,上述排出口形成接合部是由連續的曲線構成的,這是一個特徵。 In the medicinal oral administration device provided by the present invention, it is a feature that the discharge port forming joint portion is formed by a continuous curve.
這有助於黏性介質被適度截流。 This helps the viscous medium to be moderately blocked.
在本發明提供的藥劑類口服服藥裝置中,上述排出口形成接合部具有圓弧形狀,這是一個特徵。 In the medicinal oral administration device provided by the present invention, the discharge port forming joint portion has a circular arc shape, which is a feature.
這有助於黏性介質被適度截流。 This helps the viscous medium to be moderately blocked.
在本發明提供的藥劑類口服服藥裝置中,上述排出口形成接合部與上述第1側部相接,連接相對位置的上述成形材形成支撐接合部,該支撐接合部的位置比上述中間接合部更靠近開端部一側。 In the medicinal oral administration device provided by the present invention, the discharge port forming joint portion is in contact with the first side portion, and the molding material connected to the opposite position forms a support joint portion, and the position of the support joint portion is higher than the intermediate joint portion. Closer to the open end side.
這樣,由支撐接合部和排出口形成接合部圍成的空間可用於收容藥劑,有助於在形成介質包覆藥劑時,藥劑和被截流的黏性介質更好地相融為一體。 In this way, the space surrounded by the supporting joint and the discharge port forming joint can be used for accommodating medicines, which helps the medicines and the viscous medium being intercepted to better integrate when the medium is coated with the medicine.
在本發明的藥劑類口服服藥裝置中,在上述 開端部處,相對位置的上述成形材中的其中一個面上有缺口,可以露出與其相對的另一個面,這是一個特徵。 In the pharmaceutical oral administration device of the present invention, It is a feature that one side of the above-mentioned forming material at the opening end has a notch on the opposite side so that the other side opposite to it can be exposed.
這樣,將藥劑投入到藥劑類口服服藥裝置時更容易。另外,口服介質包覆藥劑時,介質包覆藥劑置於露出的成形材上,因此服用起來更方便。 In this way, it is easier to put a medicine into a medicine-type oral medicine administration device. In addition, when the medium-coated medicine is administered orally, the medium-coated medicine is placed on the exposed molding material, so it is more convenient to take.
本發明的藥劑類口服服藥裝置具有收納狀態維持部,可以維持上述開端部被至少折疊一次後,收納在閉端部中並保持這種折疊狀態,這是一個特徵。 The medicinal oral medication administration device of the present invention has a storage state maintaining unit, which can maintain the folded state of the open end portion at least once and store the closed end portion in the closed state to maintain the folded state. This is a feature.
這將利於收納狀態的保持。 This will help maintain the storage state.
在本發明的藥劑類口服服藥裝置中,上述收納狀態維持部是在上述閉端部形成的切插口結構,這是一個特徵。 In the medicinal oral administration device of the present invention, it is a feature that the storage state maintaining portion has a cut-out opening structure formed in the closed end portion.
這將利於保持收納狀態。 This will help to keep the storage state.
在本發明的藥劑類口服服藥裝置中,上述收納狀態維持部是在與上述黏性介質封入部相反方向上連接在上述閉端部上,並且其上與上述閉端部不相連的端部呈開口狀,可將與上述折疊收納狀態下的閉端部相對的端部收納固定在此開口處。 In the pharmaceutical oral administration device of the present invention, the storage state maintaining portion is connected to the closed end portion in a direction opposite to the viscous medium sealing portion, and an end portion not connected to the closed end portion is The shape of the opening is such that the end opposite to the closed end in the folded storage state can be stored and fixed at this opening.
這將利於保持收納狀態。 This will help to keep the storage state.
在本發明的藥劑類口服服藥裝置中,上述收納狀態維持部形成在上述第1側部或/和第2側部上,包括相對於上述中間接合部更靠近上述開端部一側的插口和相對於上述中間接合部更靠近於上述閉端部一側的插口,並且兩者能夠相互插入嵌合,這是一個特徵。 In the medicinal oral administration device of the present invention, the storage state maintaining portion is formed on the first side portion and / or the second side portion, and includes a socket closer to the open end side than the intermediate joint portion, and an opposite side. It is a feature that the middle joint portion is closer to the socket on the side of the closed end portion, and the two can be inserted and fitted to each other.
這將有利於保持收納狀態。 This will help to keep the storage state.
在本發明的藥劑類口服服藥裝置中,裝入有指定的上述藥劑類。 The pharmaceutical orally administered device of the present invention contains the above-mentioned specified pharmaceuticals.
這樣可以提供裝有藥劑的藥劑類口服服藥裝置。 This can provide a medicament-type oral administration device containing a medicament.
100‧‧‧藥劑類口服服藥裝置 100‧‧‧ Pharmacy Oral Medication Device
101‧‧‧接合側部 101‧‧‧Joint side
101a‧‧‧傾斜側部 101a‧‧‧ inclined side
102‧‧‧折疊側部 102‧‧‧Folding side
103‧‧‧閉端部 103‧‧‧ closed end
104‧‧‧開端部 104‧‧‧ Beginning
104a‧‧‧第1開端部 104a‧‧‧First opening
104b‧‧‧第2開端部 104b‧‧‧ 2nd opening
104c‧‧‧缺口 104c‧‧‧ gap
105‧‧‧中間接合部 105‧‧‧ intermediate joint
105a‧‧‧第1中間接合部 105a‧‧‧1st intermediate joint
105b‧‧‧第2中間接合部 105b‧‧‧ 2nd intermediate joint
106‧‧‧排出口形成接合部 106‧‧‧ discharge port forms a joint
106a‧‧‧第1傾斜接合部 106a‧‧‧1st inclined joint
106b‧‧‧第2傾斜接合部 106b‧‧‧ 2nd inclined joint
106c‧‧‧支撐接合部 106c‧‧‧ support joint
106d‧‧‧排出口 106d‧‧‧Exhaust
106t‧‧‧端部 106t‧‧‧end
L106d‧‧‧黏性介質移動線 L106d‧‧‧Viscose medium moving line
107‧‧‧收納狀態維持部 107‧‧‧Storage state maintenance section
201‧‧‧藥劑配置部 201‧‧‧Pharmaceutical Disposition Department
203‧‧‧黏性介質封入部 203‧‧‧Viscous Media Enclosure
205‧‧‧藥劑收容部 205‧‧‧Pharmaceutical Containment Department
300‧‧‧藥劑類口服服藥裝置 300‧‧‧ Pharmacy Oral Medication Device
307‧‧‧收納狀態維持部 307‧‧‧Storage State Maintenance Department
400‧‧‧藥劑類口服服藥裝置 400‧‧‧ Pharmacy Oral Medication Device
407‧‧‧收納狀態維持部 407‧‧‧Storage State Maintenance Department
407a‧‧‧第1插口 407a‧‧‧Socket 1
407b‧‧‧第2插口 407b‧‧‧ 2nd socket
407c‧‧‧第3插口 407c‧‧‧3rd socket
407d‧‧‧第4插口 407d‧‧‧4th socket
500‧‧‧藥劑類口服服藥裝置 500‧‧‧ Pharmacy Oral Medication Device
506‧‧‧排出口形成接合部 506‧‧‧ discharge port forms a joint
600‧‧‧藥劑類口服服藥裝置 600‧‧‧ Pharmacy Oral Medication Device
700‧‧‧藥劑類口服服藥裝置 700‧‧‧ Pharmacy Oral Medication Device
701‧‧‧接合側部 701‧‧‧Joint side
800‧‧‧藥劑類口服服藥裝置 800‧‧‧ Pharmacy Oral Medication Device
802‧‧‧接合側部 802‧‧‧Joint side
900‧‧‧藥劑類口服服藥裝置 900‧‧‧ Pharmacy Oral Medication Device
1000‧‧‧藥劑類口服服藥裝置 1000‧‧‧ Pharmacy Oral Medication Device
[圖1]本發明提供的藥劑類口服服藥裝置的其中一個實施例的藥劑類口服服藥裝置100的正視圖。 [FIG. 1] A front view of a pharmaceutical oral medication device 100 according to one embodiment of the pharmaceutical oral medication device provided by the present invention.
[圖2]圖1所示藥劑類口服服藥裝置100的後視圖。 [Fig. 2] A rear view of the medicinal oral medication administration device 100 shown in Fig. 1. [Fig.
[圖3]藥劑類口服服藥裝置100的使用方法示意圖。 [Fig. 3] A schematic diagram of a method of using the pharmaceutical oral medication device 100. [Fig.
[圖4]藥劑類口服服藥裝置100的使用方法示意圖。 [Fig. 4] A schematic diagram of a method of using the pharmaceutical oral medication device 100. [Fig.
[圖5]藥劑類口服服藥裝置100的使用方法示意圖。 [Fig. 5] A schematic diagram of a method for using the pharmaceutical oral administration device 100. [Fig.
[圖6]藥劑類口服服藥裝置100的使用方法示意圖。 [Fig. 6] A schematic diagram of a method of using the pharmaceutical oral administration device 100. [Fig.
[圖7]藥劑類口服服藥裝置100的使用方法示意圖。 FIG. 7 is a schematic diagram showing a method of using the pharmaceutical oral administration device 100.
[圖8]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [FIG. 8] A schematic diagram of another embodiment of a pharmaceutical oral medication device provided by the present invention.
[圖9]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [FIG. 9] A schematic diagram of another embodiment of a medicinal oral medication device provided by the present invention.
[圖10]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [Fig. 10] A schematic diagram of another embodiment of a medicinal oral medication device provided by the present invention.
[圖11]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [FIG. 11] A schematic diagram of another embodiment of a pharmaceutical oral medication device provided by the present invention.
[圖12]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [FIG. 12] A schematic diagram of another embodiment of a medicinal oral medication device provided by the present invention.
[圖13]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 FIG. 13 is a schematic diagram of another embodiment of a pharmaceutical oral medication device provided by the present invention.
[圖14]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 14 is a schematic diagram of another embodiment of a medicinal oral medication device provided by the present invention.
[圖15]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [FIG. 15] A schematic diagram of another embodiment of a pharmaceutical oral medication device provided by the present invention.
[圖16]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [FIG. 16] A schematic diagram of another embodiment of a pharmaceutical oral medication device provided by the present invention.
[圖17]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [FIG. 17] A schematic diagram of another embodiment of a pharmaceutical oral medication device provided by the present invention.
[圖18]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 FIG. 18 is a schematic diagram of another embodiment of a pharmaceutical oral medication device provided by the present invention.
[圖19]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [FIG. 19] A schematic diagram of another embodiment of a pharmaceutical oral medication device provided by the present invention.
[圖20]本發明提供的藥劑類口服服藥裝置的其他實施例的示意圖。 [Fig. 20] A schematic diagram of another embodiment of a medicinal oral medication device provided by the present invention.
[圖21]已有技術的藥劑類口服服藥裝置結構示意圖。 [Fig. 21] Schematic diagram of the structure of a conventional oral medication device for medicaments.
以下參照附圖對本發明的實施例進行詳細說明。 Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.
下面使用圖1和圖2對本發明提供的藥劑類口服服藥裝置其中一個實施例的藥劑類口服服藥裝置100進行說明。圖1是藥劑類口服服藥裝置100的正視圖,圖2是藥劑類口服服藥裝置100的後視圖,分成兩個圖展示。 The pharmaceutical oral administration device 100 according to an embodiment of the present invention is described below with reference to FIGS. 1 and 2. FIG. 1 is a front view of the pharmaceutical oral medication device 100, and FIG. 2 is a rear view of the pharmaceutical oral medication device 100, which is shown in two figures.
藥劑類口服服藥裝置100是將諸如聚丙烯或聚乙烯等平面薄片材料融接在一起而加工製成。 The medicament-type oral medication device 100 is manufactured by fusing together flat sheet materials such as polypropylene or polyethylene.
如圖1所示,藥劑類口服服藥裝置100具有接合側部101、折疊側部102、閉端部103、開端部104、中間接合部105、排出口形成接合部106以及收納狀態維持部107。 As shown in FIG. 1, the medicinal oral administration device 100 includes a joining side portion 101, a folding side portion 102, a closed end portion 103, an open end portion 104, an intermediate joining portion 105, a discharge port forming joining portion 106, and a storage state maintaining portion 107.
藥劑類口服服藥裝置100是將一張薄片材料的兩個側邊加熱融接,形成側部接合區域101r,從而形成的筒狀結構。即在側部接合區域101r上,將開端部104的一個端部104T1和與之相應的閉端部103的一個端部103T1相連接而形成接合側部101。接合側部101上設有傾斜側部101a。傾斜側部101a是從開端部104向閉端部103方向向外傾斜形成的。傾斜側部101a與排出口形成接合部106,特別是第2傾斜接合部106b(見下述)的位置相對應。同時,在側部接合區域101r中,折疊側部102(見下述)的對邊--接合側部101和與該接合側部101相對的側邊--外側部101e相互平行。 The medicinal oral medication device 100 is a tubular structure formed by heating and fusing the two sides of a sheet of material to form a side joint region 101r. That is, one end portion 104T1 of the open end portion 104 and one end portion 103T1 of the corresponding closed end portion 103 are connected to each other on the side joint area 101r to form the joint side portion 101. The joint side portion 101 is provided with an inclined side portion 101a. The inclined side portion 101 a is formed by being inclined outward from the open end portion 104 toward the closed end portion 103. The inclined side portion 101a corresponds to the position of the discharge port forming joint portion 106, particularly the second inclined joint portion 106b (see below). Meanwhile, in the side joint region 101r, the opposite side of the folded side portion 102 (see below) —the joint side portion 101 and the side opposite to the joint side portion—the outer portion 101e are parallel to each other.
折疊側部102的位置與接合側部101的位置相對。在形成接合側部101以後進而成為筒狀的薄片被壓成平面形狀,由此而形成的側邊上連接開端部104的一個端部104T2和與之相應的閉端部103的一個端部103T2就形成了折疊側部102。 The position of the folded side portion 102 is opposite to the position of the joined side portion 101. After the joining side portion 101 is formed, the sheet that has become a cylindrical shape is pressed into a flat shape, and the side formed thereby connects one end portion 104T2 of the open end portion 104 and one end portion 103T2 of the closed end portion 103 corresponding thereto. The folded side portion 102 is formed.
將已形成接合側部101後成為筒狀的薄片的一個端部加熱融接而形成閉端部103。藥劑類口服服藥裝置100是由接合側部101、折疊側部102及閉端部103形成三側閉合的類似袋狀的結構。 One end portion of the sheet that has been formed into a cylindrical shape after the joining side portion 101 has been formed is heated and fused to form a closed end portion 103. The pharmaceutical-type oral medication administration device 100 has a bag-like structure in which three sides are closed by joining the side portion 101, the folded side portion 102, and the closed end portion 103.
開端部104與閉端部103的位置相對。開端部104由第1開端部104a和第2開端部104b構成。第1開端部104a和第2開端部104b相向而設置。如圖1和圖2所示,只有第2開端部104b上形成有一個半圓形的缺口104c。這樣一來,第1開端部104a可從中露出,便於通過缺口104c投放藥劑,也有利於和藥劑融為一體的黏性介質的排出、服用。 The open end portion 104 is opposed to the closed end portion 103. The open end portion 104 includes a first open end portion 104a and a second open end portion 104b. The first opening end portion 104a and the second opening end portion 104b face each other. As shown in FIGS. 1 and 2, only a semicircular notch 104 c is formed in the second opening end portion 104 b. In this way, the first opening end portion 104a can be exposed therefrom, which facilitates the administration of the medicine through the notch 104c, and also facilitates the discharge and administration of the viscous medium integrated with the medicine.
中間接合部105位於接合側部101和折疊側部102間的橫截位置。中間接合部105由第1中間接合部105a和第2中間接合部105b構成。第1中間接合部105a和第2中間接合部105b基本平行,且第1中間接合部105a相對於第2中間接合部105b而言更靠近閉端部103一側。 The intermediate joint portion 105 is located at a cross-sectional position between the joint side portion 101 and the folded side portion 102. The intermediate joint portion 105 includes a first intermediate joint portion 105 a and a second intermediate joint portion 105 b. The first intermediate joint portion 105a and the second intermediate joint portion 105b are substantially parallel, and the first intermediate joint portion 105a is closer to the closed end portion 103 side than the second intermediate joint portion 105b.
中間接合部105是在將黏性介質導入黏性介質封入部203(見下述)後,將該部位的薄片加熱後融接 而形成的。中間接合部105可以阻止攜帶和搬運時,黏性介質受震動而從黏性介質封入部203中外流,同時,服藥時,又不會阻礙黏性介質順暢地從黏性介質封入部203中排出。中間接合部105的融接強度設定在當黏性介質封入部203的內壓高於規定值時其可以剝離開的程度。 The intermediate joint portion 105 is obtained by introducing a viscous medium into the viscous medium sealing portion 203 (see below), and then heating and fusing the sheet at this portion. Formed. The intermediate joint portion 105 can prevent the viscous medium from flowing out of the viscous medium sealing portion 203 during carrying and carrying, and at the same time, it does not prevent the viscous medium from being smoothly discharged from the viscous medium sealing portion 203 when taking the medicine. . The welding strength of the intermediate joint portion 105 is set to such an extent that it can be peeled off when the internal pressure of the viscous medium sealing portion 203 is higher than a predetermined value.
排出口形成接合部106位於黏性介質封入部203與藥劑配置部201(見下述)之間,用於適度地截流黏性介質。排出口形成接合部106處於接合側部101與折疊側部102之間的某特定位置且與折疊側部102相連,並且從開端部104一側向閉端部103方向呈向下傾斜的趨勢。排出口形成接合部106上靠近開端部104一側的端部106t到接合側部101的距離是定值。 The discharge port forming joint portion 106 is located between the viscous medium sealing portion 203 and the medicine disposing portion 201 (see below), and is used for moderately blocking the viscous medium. The discharge port forming joint portion 106 is located at a specific position between the joint side portion 101 and the folded side portion 102 and is connected to the folded side portion 102, and is inclined downward from the open end portion 104 side toward the closed end portion 103. The distance from the end portion 106t of the discharge port forming joint portion 106 on the side close to the open end portion 104 to the joint side portion 101 is constant.
排出口形成接合部106上具有黏性介質的排出口106d。排出口106d是中間接合部105的接合被破壞後,黏性介質從黏性介質封入部203流向藥劑配置部201時的通過口。排出口106d位於接合側部101和排出口形成結合部106的端部106t之間。排出口106d的開口小於中間接合部105部位的接合側部101與折疊側部102間的間距。 The discharge port forms a discharge port 106 d having a viscous medium in the joint portion 106. The discharge port 106d is a passage port when the viscous medium flows from the viscous medium sealing portion 203 to the medicine disposing portion 201 after the bonding of the intermediate bonding portion 105 is broken. The discharge port 106d is located between the joining side portion 101 and the end portion 106t of the discharge port forming joint portion 106. The opening of the discharge port 106d is smaller than the distance between the joint side portion 101 and the folded side portion 102 at the middle joint portion 105.
排出口形成接合部106具有第1傾斜接合部106a、第2傾斜接合部106b和支撐結合部106c。黏性介質沿著由第1傾斜接合部106a和第2傾斜接合部106b形成的黏性介質移動線L106移動。第1傾斜接合部106a和第2傾斜接合部106b均從開端部104向閉端部103方 向呈向下傾斜狀,但第1傾斜結合部106a和第2傾斜接合部106b的傾斜角度彼此不同,也就是說,整個排出口形成結合部106上的傾斜角度不一致。和第2傾斜接合部106b相比,第1傾斜接合部106a的傾斜角度更緩和,而且第1傾斜接合部106a比第2傾斜接合部106b的位置更靠近開端部104一側。 The discharge port forming joint 106 includes a first inclined joint 106a, a second inclined joint 106b, and a support joint 106c. The viscous medium moves along the viscous medium moving line L106 formed by the first inclined joint portion 106a and the second inclined joint portion 106b. Both the first inclined joint portion 106a and the second inclined joint portion 106b extend from the open end portion 104 to the closed end portion 103. It is inclined downward, but the inclination angles of the first inclined joint portion 106a and the second inclined joint portion 106b are different from each other, that is, the inclination angles on the entire discharge port forming joint portion 106 are not the same. The inclination angle of the first inclined joint portion 106a is more gentle than that of the second inclined joint portion 106b, and the position of the first inclined joint portion 106a is closer to the open end portion 104 than the position of the second inclined joint portion 106b.
這樣,傾斜角度不同的第1傾斜接合部106a和第2傾斜結合部106b相連接,可以使一定量的黏性介質更加平穩地從排出口106d排出。將傾斜角度不同的傾斜接合部相連接而構成的結構可以促進一定量的黏性介質從排出口106d平穩排出這一結論是發明人通過實驗結果得出的。 In this way, the first inclined joint portion 106a and the second inclined joint portion 106b having different inclination angles are connected, and a certain amount of viscous medium can be more smoothly discharged from the discharge port 106d. The conclusion that the structure formed by connecting inclined joints with different inclination angles can promote a certain amount of viscous medium to be smoothly discharged from the discharge port 106d is obtained by the inventor through experimental results.
支撐接合部106c是從第1傾斜接合部106a與第2傾斜接合部106b的接合點附近某處為起點一直延伸到折疊側部102的結構。排出口形成接合部106的端部106t比第2中間結合部105b更靠近開端部104一側。 The support joint portion 106 c extends from the vicinity of the joint between the first inclined joint portion 106 a and the second inclined joint portion 106 b to the folded side portion 102 as a starting point. The end portion 106t of the discharge port forming joint portion 106 is closer to the open end portion 104 side than the second intermediate joint portion 105b.
收納狀態維持部107形成在閉端部103上。收納狀態維持部107上的插口寬度要比開端部104的寬度大。這樣,將處於折疊彎曲狀態(見下述)的開端部104的外端,即與閉端部103不同的收納端插入到收納狀態維持部107中就更容易了。 The storage state maintaining portion 107 is formed on the closed end portion 103. The width of the socket on the storage state maintaining portion 107 is larger than the width of the open end portion 104. In this way, it is easier to insert the outer end of the open end portion 104 in a folded state (see below), that is, a storage end different from the closed end portion 103 into the storage state maintaining portion 107.
由接合側部101、折疊側部102及第2中間接合部105b圍成的空間為藥劑配置部201。藥劑配置部201內放置有規定的藥劑T,藥劑T可以是片劑、膠囊、顆粒 等任何形狀的藥劑。圖1中舉例所示的藥劑是片劑類藥劑。 A space surrounded by the joining side portion 101, the folding side portion 102, and the second intermediate joining portion 105b is a medicine disposing portion 201. A prescribed medicine T is placed in the medicine disposing unit 201, and the medicine T may be a tablet, capsule, or granule Wait for any shape of medicine. The medicine shown in FIG. 1 is a tablet medicine.
由接合側部101、折疊側部102、閉端部103及第1中間接合部105a圍成的空間為黏性介質封入部203。黏性介質封入部203中封入有能夠在形成單個包覆藥劑的基礎上,將單個包覆藥劑融為一體,以形成介質包覆藥劑的黏性介質。本實施例中使用的黏性介質為果膠類黏性體。在黏性介質的輔助作用下,即便是有藥劑吞咽困難的患者也可以採用口服方式服藥。 The space surrounded by the joining side portion 101, the folding side portion 102, the closed end portion 103, and the first intermediate joining portion 105a is a viscous medium sealing portion 203. The viscous medium sealing portion 203 is sealed with a viscous medium capable of melting a single coated medicine into a whole on the basis of forming a single coated medicine. The viscous medium used in this embodiment is a pectin-based viscous body. With the help of viscous media, even patients with difficulty swallowing the drug can take the drug by mouth.
由第1傾斜接合部106a、支撐接合部106c及折疊側部102包圍形成的空間為藥劑收容部205。藥劑收容部205可以使藥劑穩定地保持在該部位。這樣,服藥者在使用藥劑類口服服藥裝置100服藥時,藥劑可始終收容在該部位,不會移動到其他部位,更能方便、集中地混合藥劑和黏性介質。 A space formed by being surrounded by the first inclined joint portion 106a, the support joint portion 106c, and the folded side portion 102 is a medicine storage portion 205. The medicine accommodating portion 205 can stably hold the medicine at this portion. In this way, when taking medicine using the medicine-type oral medicine administration device 100, the medicine can be stored in the part at all times without moving to other parts, and the medicine and the viscous medium can be more conveniently and concentratedly mixed.
使用藥劑類口服服藥裝置時,主要分成兩個階段。一個是將片劑T等藥劑封入藥劑配置部201的準備階段,另一個是口服介質包覆藥劑的服用階段。以下分別對各階段進行說明。 When using a pharmaceutical oral medication device, there are two main stages. One is a preparation stage of encapsulating a medicine such as a tablet T in the medicine disposing unit 201, and the other is a stage of taking the medicine coated with an oral medium. Each phase is explained below.
在準備階段,在黏性介質封入部203內已事先封入有 一定黏性介質的狀態下,藥劑類口服服藥裝置100被提供給需要封入藥劑的使用者(以下,稱之為“封入者”)。下面通過圖3~圖5對藥劑口服服藥裝置100的準備階段進行說明。 In the preparation stage, the viscous medium sealing portion 203 has been sealed in advance. In a state of a certain viscous medium, the medicament-type oral medication administration device 100 is provided to a user who needs to seal the medicine (hereinafter, referred to as a "sealer"). The preparation stage of the oral medication device 100 will be described below with reference to FIGS. 3 to 5.
如圖3所示,要將藥劑T封入藥劑類口服服藥裝置100的封入者首先將藥劑T放置在開端部104,然後沿箭頭a31所指方向使藥劑T繼續移動,令其到達藥劑配置部201。此時,開端部104呈菱形開口狀態。這時,沒有缺口104c的第1開端部104a位於下方,有缺口104c的第2開端部104b位於上方,封入者通過缺口104c將片劑T放置在第1開端部104a上。放入片劑T時,封入者令開端部104呈菱形開口狀態,第1開端部104a的下側外凸(類似漏斗狀),這樣易於片劑T的聚攏收容,不易向兩側散落,防止投放失敗。 As shown in FIG. 3, the sealer who seals the medicine T in the medicine-type oral administration device 100 first places the medicine T on the opening portion 104, and then moves the medicine T in the direction indicated by the arrow a31, so that it reaches the medicine disposing unit 201. . At this time, the open end portion 104 is in a rhombic opening state. At this time, the first opening end 104a without the notch 104c is located below, and the second opening end 104b with the notch 104c is located above, and the sealer places the tablet T on the first opening end 104a through the notch 104c. When the tablet T is placed, the sealer makes the open end 104 a diamond-shaped opening state, and the lower side of the first open end 104a is convex (similar to a funnel shape), so that the tablet T can be gathered and stored, and it is not easy to be scattered to both sides, preventing Casting failed.
放入片劑T後,如圖4所示,封入者將開端部104向第2開端部104b內側方向,即按照箭頭a41所指方向彎折,使藥劑類口服服藥裝置100在開端部104的位置上對折。當將開端部104彎折時,至少要使缺口104c完全位於內側的位置上。 After inserting the tablet T, as shown in FIG. 4, the sealer bends the opening end 104 toward the inside of the second opening end 104 b, that is, bends in the direction indicated by the arrow a41, so that the oral medication device 100 for medicines is in Fold in position. When the open end portion 104 is bent, at least the notch 104c must be completely positioned on the inner side.
藥劑類口服服藥裝置100被折成兩段以後,如圖5所示,封入者在開端部104已被折疊的狀態下,繼續沿第1中間結合部105a將藥劑配置部201向黏性介質封入部203的方向,即箭頭a51所指方向彎折,然後,將藥劑配置部201上與第2中間接合部105b不同側的端 部,即開端部104被折疊後的外端部,按照箭頭a53的方向插入到收納狀態維持部107內。這樣,藥劑類口服服藥裝置100被折疊成三段,體積小巧,便於攜帶。 After the pharmaceutical oral administration device 100 is folded into two sections, as shown in FIG. 5, the sealer continues to seal the medicine disposing portion 201 into the viscous medium along the first intermediate joint portion 105 a in a state where the opening portion 104 has been folded. Bend the direction of the portion 203, that is, the direction indicated by the arrow a51, and then, the end of the medicine disposing portion 201 on the side different from the second intermediate joint portion 105b Part, that is, the outer end part after the open end part 104 is folded, is inserted into the storage state maintaining part 107 in the direction of the arrow a53. In this way, the medicament-type oral medication device 100 is folded into three sections, which is compact and convenient to carry.
接下來,參照圖6和圖7對藥劑類口服服藥裝置100的口服階段進行說明。圖6中省略了中間接合部105。 Next, the oral phase of the medicinal oral administration device 100 will be described with reference to FIGS. 6 and 7. The intermediate joint 105 is omitted in FIG. 6.
服用者本人或者他人在喂其服用收容在藥劑類口服服藥裝置100中的藥劑T時,需將圖5中折疊成三段的藥劑類口服服藥裝置100展開成如圖6所示的平面狀。 When the user himself or another person feeds him or her to take the medicine T contained in the medicine-type oral medicine-administering device 100, the medicine-type oral medicine-administering device 100 folded into three sections in FIG. 5 must be unfolded into a flat shape as shown in FIG.
在如圖6所示的平面狀態下,服藥者用手指按壓黏性介質封入部203,使得黏性介質封入部203內的壓強升高。當黏性介質封入部203內的壓強高於一定值時,中間接合部105的融接將被剝離開,這時黏性介質封入部203內的黏性介質將向藥劑配置部201的方向移動。 In a flat state as shown in FIG. 6, the user presses the viscous medium sealing portion 203 with a finger, so that the pressure in the viscous medium sealing portion 203 increases. When the pressure in the viscous medium sealing portion 203 is higher than a certain value, the fusion of the intermediate joint portion 105 will be peeled off. At this time, the viscous medium in the viscous medium sealing portion 203 will move in the direction of the medicine disposing portion 201.
此時,黏性介質沿排出口形成接合部106上的第2傾斜接合部106b及第1傾斜結合部106a,按照從箭頭a61到箭頭a65的方向排出,即黏性介質沿黏性介質移動線L106移動、排出。黏性介質從中間接合部105向排出口106d的方向移動時,由於排出口106d的開口大小要比中間接合部105上接合側部101到折疊側部102間的間距小,因此,黏性介質在黏性介質封入部203被施加的壓力,即在黏性介質從較寬的黏性介質封入部203流向 狹小的排出口106d時所受壓力以及黏性體自身的黏性等因素影響下被適度地截流。同時,黏性介質也沿接合側部101上的傾斜側部101a按照箭頭a63所指的方向排出,因此,沿箭頭a61方向及沿箭頭a63方向排出的黏性介質在箭頭交匯點附近合流,這樣也會起到截流效果。 At this time, the viscous medium forms the second inclined joint portion 106b and the first inclined joint portion 106a on the joint portion 106 along the discharge port, and is discharged in the direction from arrow a61 to arrow a65, that is, the viscous medium moves along the viscous medium moving line. L106 moves and discharges. When the viscous medium moves from the intermediate joint portion 105 to the discharge port 106d, the opening size of the discharge port 106d is smaller than the distance between the joint side portion 101 and the folded side portion 102 on the intermediate joint portion 105. Therefore, the viscous medium The pressure applied to the viscous medium sealing portion 203, that is, the viscous medium flows from the wider viscous medium sealing portion 203 to Under the influence of factors such as the pressure on the narrow discharge port 106d and the viscosity of the viscous body, it was moderately blocked. At the same time, the viscous medium is also discharged along the inclined side 101a on the joining side 101 in the direction indicated by the arrow a63. Therefore, the viscous medium discharged in the direction of the arrow a61 and the direction of the arrow a63 merges near the intersection of the arrows. Will also play a blocking effect.
截流後的黏性介質從排出口106d沿箭頭a67所示的路徑向藥劑配置部201的方向排出。在向藥劑配置部201排出時,截流後的黏性介質會朝著藥劑收容部205一側排出。由於藥劑T位於藥劑收容部205內,所以截流後的黏性介質在此與藥劑T相互融合而成為一體,由此形成介質包覆藥劑。通過揉搓藥劑T和黏性介質,藥劑可更均勻地被包覆在黏性介質中,形成均勻的介質包覆藥劑。 The viscous medium after the flow-off is discharged from the discharge port 106d in a direction indicated by an arrow a67 in the direction of the medicine disposing unit 201. When discharged to the medicine arranging section 201, the viscous medium after the flow-off is discharged toward the medicine accommodating section 205 side. Since the medicine T is located in the medicine accommodating part 205, the viscous medium after the interception and the medicine T are fused with each other to be integrated, thereby forming a medium-coated medicine. By rubbing the medicine T and the viscous medium, the medicine can be more uniformly coated in the viscous medium to form a uniform medium-coated medicine.
形成介質包覆藥劑後,如圖7所示,使介質包覆藥劑按照箭頭a71所示方向向開端部104一側移動,並到達第1開端部104a,最後從第1開端部104a處介質包覆藥劑被服用者服用。 After the medium-coated medicine is formed, as shown in FIG. 7, the medium-coated medicine is moved to the opening end 104 side in the direction shown by the arrow a71, and reaches the first opening end 104a, and finally the medium bag from the first opening end 104a The overdose is taken by the user.
(1)黏性介質:上述實施例1中所使用的黏性介質為果膠,但實際上,只要是具有一定黏度和一定強度,能夠包覆藥劑,並且能夠將多個被包覆的單個藥劑融為一體,形成介質包覆藥劑的物質都可以使用。 (1) Viscous medium: The viscous medium used in the above Example 1 is pectin, but in fact, as long as it has a certain viscosity and a certain strength, it can be coated with a medicament, and multiple coated singles can be coated. The medicament is fused into one body, and any substance that forms a medium to coat the medicament can be used.
(2)藥劑:上述實施例1中所用的藥劑為片劑T,但並非局限於此類藥劑。比如:迷你藥片、藥丸、 硬膠囊、軟膠囊、顆粒劑、粉劑、原料藥API均可。 (2) Medicament: The medicament used in the above Example 1 is the tablet T, but it is not limited to such a medicament. For example: mini tablets, pills, Hard capsules, soft capsules, granules, powders, APIs are all available.
另外,除了藥劑,也可以是用於補充必要營養素用的營養物質。 In addition to the medicament, it may be a nutrient for supplementing necessary nutrients.
材質:上述實施例1中用來製作藥劑類口服服藥裝置100的薄片材料為聚丙烯,但只要能形成中間接合部105、排出口形成接合部106和接合側部101,所用材質並不局限於此,像鋁等軟性材料也可,另外也可以採用透明或半透明材料。 Material: The sheet material used to make the medicament-type oral administration device 100 in the above embodiment 1 is polypropylene, but the material used is not limited as long as it can form the intermediate joint portion 105, the discharge port forming joint portion 106, and the joint side portion 101. Therefore, a soft material such as aluminum may be used, and a transparent or translucent material may also be used.
收納狀態維持部107:在上述實施例1中,閉端部104上的插口構成了收納狀態維持部107,但不局限於這種結構,只要能將藥劑類口服服藥裝置維持在折疊的收納狀態的結構均可以。比如,在如圖8所示的藥劑類口服服藥裝置300中,收納狀態維持部307連接在接合端部103上,與黏性介質封入部203不在相同方向,這種構造也可以。 Storage state maintenance unit 107: In the first embodiment described above, the socket on the closed end portion 104 constitutes the storage state maintenance unit 107, but it is not limited to this structure, as long as the oral medication device for medicines can be maintained in the folded storage state The structure is fine. For example, in the medicinal oral medication administration device 300 shown in FIG. 8, the storage state maintaining portion 307 is connected to the joint end portion 103 and is not in the same direction as the viscous medium sealing portion 203. This structure is also possible.
收納狀態維持部307在與接合端部103相向的位置上形成有一個收納端部用插口。如圖9所示,在開端部104被折疊的狀態下,將藥劑配置部201和黏性介質封入部203對折並使其重疊。同時,將收納狀態維持部307也與黏性介質封入部203重疊。然後,將折疊態的藥劑配置部203的一端插入到收納狀態維持部307的端部收納用插口中,攜帶藥劑類口服服藥裝置300時一直保持這種收納狀態。 The storage state maintaining portion 307 has a storage end socket formed at a position facing the joint end portion 103. As shown in FIG. 9, in a state where the open end portion 104 is folded, the medicine disposing portion 201 and the viscous medium sealing portion 203 are folded in half and overlapped. At the same time, the storage state maintaining portion 307 also overlaps the viscous medium sealing portion 203. Then, one end of the folded medicine arranging unit 203 is inserted into the end storage socket of the storage state maintaining unit 307, and the storage state is maintained when the medicine-type oral medication administration device 300 is carried.
另外,如圖10所示,藥劑類口服服藥裝置 400的收納維持狀態部407也可形成在側部接合區域101r上。收納維持狀態部407為多個插口,包括側部接合部101上與藥劑配置部203相對應的部位形成的第1插口407a和第2插口407b,以及側部接合部101上與黏性介質封入部203相對應的部位形成的第3插口407c和第4插口407d。第1插口407a和第2插口407b是從側部接合部101外側向藥劑配置部203方向形成的窄切口,第3插口407c和第4插口407c是從側部接合部101外側向黏性介質封入部203方向形成的寬切口。 In addition, as shown in FIG. 10, a medicinal oral medication device The storage maintaining state part 407 of 400 may be formed in the side joint area 101r. The storage maintaining state portion 407 is a plurality of sockets, including the first socket 407a and the second socket 407b formed on the side joint portion 101 corresponding to the medicine disposing portion 203, and the side joint portion 101 is sealed with a viscous medium. The third socket 407c and the fourth socket 407d are formed at positions corresponding to the portion 203. The first socket 407a and the second socket 407b are narrow incisions formed from the outside of the side joint 101 to the direction of the medicine disposing portion 203. The third socket 407c and the fourth socket 407c are sealed from the outside of the side joint 101 to the viscous medium. A wide cut is formed in the direction of the portion 203.
攜帶時的收納狀態如圖11A所示,在開端部104被折疊的狀態下,將圖11A中的X區域放大到圖11B,如圖11B所示,可以看到將第1插口407a和第2插口407b前端的一部分插入到第3插口407c和第4插口407d中,第1插口407a、第2插口407b與第3插口407c、第4插口407d相互插入嵌合,藥劑類口服服藥裝置400的收納狀態以這樣的方式得以保持。圖11B中第1插口407a、第2插口407b上的虛線表示與第3插口407c、第4插口407d插入嵌合的部分。 The storage state when carrying is shown in FIG. 11A. With the open end 104 folded, the X area in FIG. 11A is enlarged to FIG. 11B. As shown in FIG. 11B, the first socket 407a and the second socket can be seen. A part of the front end of the socket 407b is inserted into the third socket 407c and the fourth socket 407d. The first socket 407a, the second socket 407b, the third socket 407c, and the fourth socket 407d are inserted and fitted to each other. State is maintained in this way. The dashed lines on the first socket 407a and the second socket 407b in FIG. 11B indicate portions that are inserted into the third socket 407c and the fourth socket 407d.
(5)排出口形成接合部106的形狀:在上述實施例1中,排出口形成接合部106具有兩個傾斜角度不同的第1傾斜接合部106a和第2傾斜接合部106b,但只要是傾斜角度不同,也並不一定是與此完全相同的形狀。比如,圖12中所示的藥劑類口服服藥裝置500,其排出口形成接合部506被設計成圓弧形也未嘗不可。在這種情 況下,圓弧形的排出口形成接合部506可形成黏性介質移動線L506。 (5) Shape of discharge port forming joint 106: In the first embodiment described above, discharge port forming joint 106 has two first inclined joints 106a and second inclined joints 106b having different inclination angles, but as long as they are inclined Different angles are not necessarily exactly the same shape. For example, the medicine-type oral medication administration device 500 shown in FIG. 12 may have a discharge port forming joint portion 506 that is designed to be arc-shaped. In this situation In this case, the arc-shaped discharge opening forming joint 506 can form a viscous medium moving line L506.
另外,像圖13中的藥劑類口服服藥裝置550一樣,也可將上述實施例1中藥劑類口服服藥裝置100的第1傾斜接合部106a和第2傾斜接合部106b分割成多個傾斜接合部,即形成多個分割傾斜接合部206a~206d,在這種情況下,各個分割傾斜接合部之間的間距控制在黏性介質不會從其間隙中漏出,且能保證黏性介質沿各個分割傾斜接合部正常移動的大小即可。在這種情況下,由於黏性介質沿分割傾斜接合部206a~206d移動,因此分割傾斜接合部206a~206d及彼此之間的間隙形成了黏性介質移動線L206。 In addition, like the pharmaceutical oral administration device 550 in FIG. 13, the first inclined joint 106 a and the second inclined joint 106 b of the pharmaceutical oral administration device 100 in the first embodiment may be divided into a plurality of inclined joints. That is, a plurality of divided inclined joints 206a to 206d are formed. In this case, the distance between the divided inclined joints is controlled so that the viscous medium does not leak out of the gap, and the viscous medium can be guaranteed to be divided along the respective divisions. It is sufficient if the inclined joint portion moves normally. In this case, since the viscous medium moves along the divided inclined joint portions 206a to 206d, the divided inclined joint portions 206a to 206d and the gap between them form a viscous medium moving line L206.
(6)支撐接合部106c:上述實施例1中藥劑類口服服藥裝置100的排出口形成接合部106上具有支撐接合部106c,然而,如圖14中的藥劑類口服服藥裝置600,也可以沒有支撐接合部106c。或者,也可將圖1中的支撐接合部106c與第2傾斜接合部106b之間的空間加熱融接,將第1傾斜接合部101a、第2傾斜接合部101b及支撐接合部106c變成一體。 (6) Support joint 106c: The outlet of the medicinal oral medication administration device 100 in the first embodiment described above has a support joint 106c on the joint 106. However, as shown in FIG. 14, the medicinal oral medication administration device 600 may be omitted. Support joint 106c. Alternatively, the space between the support joint portion 106c and the second inclined joint portion 106b in FIG. 1 may be heat-fused, and the first inclined joint portion 101a, the second inclined joint portion 101b, and the support joint portion 106c may be integrated.
(7)側部接合區域101r:上述實施例1中藥劑類口服服藥裝置100的側部接合區域101r上形成有相互平行的接合側部101和外側部101e,但只要是能形成一定形狀的接合側部101,也不局限於實施例1中的形狀。比如,圖15中藥劑類口服服藥裝置650上就形成有 外側部651e和接合側部101為兩種不同形狀的側部接合區域651r。 (7) Side joint area 101r: The side joint area 101r of the pharmaceutical oral administration device 100 in the first embodiment described above is formed with the joint side portion 101 and the outer portion 101e parallel to each other, but as long as it can form a certain shape of joint The side portion 101 is also not limited to the shape in the first embodiment. For example, the medicine-type oral medication device 650 in FIG. 15 is formed with The outer portion 651e and the joining side portion 101 are two differently-shaped side joining regions 651r.
(8)傾斜側部101a:上述實施例1中藥劑類口服服藥裝置100的接合側部101上具有傾斜側部101a,然而,圖16所示藥劑類口服服藥裝置700的接合側部701卻不具有傾斜側部,這也是可行的。在這種情況下,開端部104的一個端部104T1和與之相對應的閉端部703的一個端部703T1被連接在側部接合區域701r上,由此形成直線狀的接合側部701。同時,在由接合側部101形成的筒狀結構的薄片被壓成平面形狀而形成的側邊上連接開端部104的一個端部104T2和與之相對應的閉端部703的一個端部703T2,由此形成直線狀的折疊側部102。 (8) Inclined side portion 101a: The joint side portion 101 of the medicinal oral administration device 100 in the above embodiment 1 has the oblique side portion 101a. However, the joint side portion 701 of the medicinal oral administration device 700 shown in FIG. It is also possible to have inclined sides. In this case, one end portion 104T1 of the open end portion 104 and one end portion 703T1 of the closed end portion 703 corresponding thereto are connected to the side joint region 701r, thereby forming a linear joint side portion 701. At the same time, one end portion 104T2 of the open end portion 104 and one end portion 703T2 of the closed end portion 703 corresponding thereto are connected to the side formed by pressing the sheet of the tubular structure formed by the joining side portion 101 into a flat shape. Thus, a linear folded side portion 102 is formed.
(9)藥劑類口服服藥裝置100的筒形形狀:如圖1所示,上述實施例1中的藥劑類口服服藥裝置100是將一張薄片的側邊受熱融接後,形成其中一個側部為接合側部101的筒狀結構。然而,形成筒狀結構的方法不局限於此。比如,也可以將兩張薄片的兩個側邊融接,如圖17所示的藥劑類口服服藥裝置800,其中一個側部成為接合側部101,另一個側部成為接合側部802,這樣也是可以的。 (9) Cylindrical shape of the pharmaceutical oral medication device 100: As shown in FIG. 1, the pharmaceutical oral medication device 100 in the above embodiment 1 is formed by heating and fusing the sides of a sheet to form one of the sides It is a cylindrical structure that joins the side portion 101. However, the method of forming the cylindrical structure is not limited to this. For example, the two sides of the two sheets can also be fused, as shown in FIG. 17 for a pharmaceutical oral administration device 800, where one side becomes the joining side 101 and the other side becomes the joining side 802. it is also fine.
(10)中間接合部105:上述實施例1中的中間接合部105由第1中間接合部105a和第2中間接合部105b構成。然而,不局限於此,只一個中間接合部也是 可行的,抑或三個以上也可以。 (10) Intermediate joint portion 105: The intermediate joint portion 105 in the first embodiment is composed of a first intermediate joint portion 105a and a second intermediate joint portion 105b. However, it is not limited to this, and only one intermediate joint is also It works, or more than three.
(11)排出口形成部:在上述實施例1中,排出口形成接合部106可將排出的黏性介質截流,在此處形成了黏性介質截流部。然而,沒有排出口形成接合部106,也可以形成黏性介質的截流部。比如,圖18所示的藥劑類口服服藥裝置800,其排出口形成部806位於黏性介質封入部203與藥劑配置部201之間。排出口形成接合部806是通過將位置相對的成形材加熱融接成一種類似海島的形狀而形成的。排出口形成接合部806由排出口形成接合部806a和806b構成。當黏性介質破壞掉中間接合部105的接合而從黏性介質封入部203向藥劑配置部201移動時,黏性介質會流過由排出口形成接合部806a和806b形成的排出口806d1~806d3。該排出口806d1~806d3的大小均小於中間接合部105上從接合側部101到折疊側部102的間距。 (11) Discharge port formation portion: In the above-mentioned Embodiment 1, the discharge port formation joint portion 106 can intercept the discharged viscous medium, and a viscous medium interception portion is formed here. However, without the discharge port forming the joint portion 106, a viscous medium blocking portion may be formed. For example, in the medicinal oral medication administration device 800 shown in FIG. 18, the discharge port forming portion 806 is located between the viscous medium sealing portion 203 and the medicine disposing portion 201. The discharge port forming joint 806 is formed by heating and fusing the formed materials facing each other into a sea-island-like shape. The discharge port formation engaging portion 806 is composed of the discharge port formation engaging portions 806a and 806b. When the viscous medium breaks the joint of the intermediate joint portion 105 and moves from the viscous medium sealing portion 203 to the medicine disposing portion 201, the viscous medium flows through the discharge ports 806d1 to 806d3 formed by the discharge port forming joints 806a and 806b . The sizes of the discharge ports 806d1 to 806d3 are smaller than the distance from the joint side portion 101 to the folded side portion 102 on the intermediate joint portion 105.
(12)排出口:上述實施例1中的藥劑類口服服藥裝置100僅具有一個排出口106d,但也可以具有多個排出口106d。比如,圖19中的藥劑類口服服藥裝置900具有一個海島形狀的島狀接合部906a,島狀接合部906a的上、下方各有一個排出口906d1和906d2。 (12) Discharge port: The medicinal oral administration device 100 in the above-mentioned embodiment 1 has only one discharge port 106d, but may have multiple discharge ports 106d. For example, the medicinal oral medication administration device 900 in FIG. 19 has an island-shaped island-shaped engaging portion 906a, and the island-shaped engaging portion 906a has an outlet port 906d1 and 906d2, respectively.
(13)藥劑類口服服藥裝置的形狀:上述實施例1中的藥劑類口服服藥裝置是由接合側部101、折疊側部102以及閉端部103閉合而成的筒狀結構。然而,未必僅局限於該種形狀,只要是三面閉合的結構,其他結構 也可以。比如,如圖20所示,藥劑類口服服藥裝置1000的外形為魚的形狀。 (13) Shape of pharmaceutical oral medication device: The pharmaceutical oral medication device in the first embodiment described above is a cylindrical structure formed by closing the joining side portion 101, the folding side portion 102, and the closed end portion 103. However, it is not necessarily limited to this shape, as long as it is a three-sided closed structure, other structures Yes. For example, as shown in FIG. 20, the external shape of the medicine-type oral medication administration device 1000 is the shape of a fish.
利用本發明生產的是一種可對藥劑和黏性介質在分離狀態下進行收納,便於攜帶,服藥時,服用的是黏性介質和藥劑混合後形成的介質包覆藥劑,這樣一種藥劑類口服服藥裝置。 The invention produces a medicinal agent and a viscous medium which can be stored in a separated state and is easy to carry. When taking the medicine, the agent is a medium formed by mixing the viscous medium and the medicinal agent. Such an agent is orally administered. Device.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
??PCT/JP2013-083958 | 2013-12-18 | ||
PCT/JP2013/083958 WO2015092888A1 (en) | 2013-12-18 | 2013-12-18 | P.o. medicine administration device |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201532601A TW201532601A (en) | 2015-09-01 |
TWI662959B true TWI662959B (en) | 2019-06-21 |
Family
ID=53402283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103138906A TWI662959B (en) | 2013-12-18 | 2014-11-10 | Pharmacy oral medication device |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP6168160B2 (en) |
TW (1) | TWI662959B (en) |
WO (1) | WO2015092888A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811338B1 (en) * | 1999-10-08 | 2004-11-02 | The Procter & Gamble Company | Disposable semi-enclosed applicator for distributing a substance onto a target surface |
JP2011194048A (en) * | 2010-03-19 | 2011-10-06 | Jms Co Ltd | Medical container |
WO2011122640A1 (en) * | 2010-03-29 | 2011-10-06 | 株式会社モリモト医薬 | Container for orally ingested pharmaceutical composition |
WO2012150704A1 (en) * | 2011-05-02 | 2012-11-08 | 株式会社モリモト医薬 | Container for administering medication |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4776589B2 (en) * | 2007-06-19 | 2011-09-21 | 敏彦 仁科 | Auxiliary container for drug use |
JP3173017U (en) * | 2011-11-01 | 2012-01-19 | 葉子 斉藤 | Drug taking device |
-
2013
- 2013-12-18 JP JP2015553279A patent/JP6168160B2/en active Active
- 2013-12-18 WO PCT/JP2013/083958 patent/WO2015092888A1/en active Application Filing
-
2014
- 2014-11-10 TW TW103138906A patent/TWI662959B/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811338B1 (en) * | 1999-10-08 | 2004-11-02 | The Procter & Gamble Company | Disposable semi-enclosed applicator for distributing a substance onto a target surface |
JP2011194048A (en) * | 2010-03-19 | 2011-10-06 | Jms Co Ltd | Medical container |
WO2011122640A1 (en) * | 2010-03-29 | 2011-10-06 | 株式会社モリモト医薬 | Container for orally ingested pharmaceutical composition |
WO2012150704A1 (en) * | 2011-05-02 | 2012-11-08 | 株式会社モリモト医薬 | Container for administering medication |
Also Published As
Publication number | Publication date |
---|---|
JP6168160B2 (en) | 2017-07-26 |
JPWO2015092888A1 (en) | 2017-03-16 |
TW201532601A (en) | 2015-09-01 |
WO2015092888A1 (en) | 2015-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI450845B (en) | Multiple chamber container with mistake proof administration system | |
KR101949189B1 (en) | Container for administering medication | |
TWI401076B (en) | Method for reinforcing weak sealed portion of multi-chamber medical container | |
US12076298B2 (en) | Pharmacy bag with integrated flush option | |
TW201235032A (en) | Medical administering set | |
CN103445961A (en) | Liquid medicine bag for PD (Peritoneal Dialysis) | |
TWI662959B (en) | Pharmacy oral medication device | |
US20160235627A1 (en) | Divided packet, method of manufacturing divided packet, and device for manufacturing divided packet | |
TW201200426A (en) | Handling | |
KR20120087960A (en) | Connector set for medical container | |
KR102645146B1 (en) | Packaging Pouch for easy opening and easy drinking liquid | |
JP5873483B2 (en) | Medication container | |
KR101021156B1 (en) | Medicine packing paper | |
CN108379073A (en) | Multi-cavity chamber infusion bag | |
JP2024155767A (en) | A double-packaged pouch that is easy to open and drink liquids | |
JP7285825B2 (en) | Administering device and manufacturing method thereof | |
JP2015054203A (en) | Medical double-chamber container | |
JP2005137426A (en) | Multi-chamber transfusion container and multi-chamber transfusion container containing medicament | |
KR20150106490A (en) | Medicine Packet Having Extension Part | |
KR20110004187U (en) | Packing sheet to drug |